Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Skin Diseases, Bacterial | 1 | 2017 | 105 | 0.64 | Why? |
| Soft Tissue Infections | 1 | 2017 | 116 | 0.62 | Why? |
| Adipose Tissue | 2 | 2019 | 612 | 0.58 | Why? |
| Escherichia coli Infections | 1 | 2018 | 348 | 0.54 | Why? |
| Staphylococcal Infections | 3 | 2019 | 1099 | 0.52 | Why? |
| Urinary Tract Infections | 1 | 2018 | 534 | 0.46 | Why? |
| Staphylococcus aureus | 1 | 2017 | 844 | 0.41 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.41 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.35 | Why? |
| Bacterial Infections | 1 | 2017 | 2229 | 0.26 | Why? |
| Endocarditis | 2 | 2019 | 368 | 0.25 | Why? |
| Sepsis | 1 | 2019 | 3517 | 0.24 | Why? |
| Sodium-Hydrogen Exchanger 1 | 1 | 2020 | 23 | 0.22 | Why? |
| Glucose Transporter Type 1 | 1 | 2020 | 30 | 0.22 | Why? |
| Hepatolenticular Degeneration | 1 | 2021 | 62 | 0.21 | Why? |
| Adipogenesis | 1 | 2019 | 38 | 0.21 | Why? |
| Immunity, Innate | 2 | 2019 | 6570 | 0.20 | Why? |
| Voriconazole | 1 | 2021 | 206 | 0.19 | Why? |
| Erysipelas | 1 | 2017 | 5 | 0.18 | Why? |
| Basic Reproduction Number | 2 | 2020 | 2676 | 0.18 | Why? |
| Adipocytes | 1 | 2019 | 173 | 0.18 | Why? |
| Peritonitis | 2 | 2019 | 217 | 0.18 | Why? |
| Aspergillus fumigatus | 1 | 2021 | 239 | 0.18 | Why? |
| 3T3-L1 Cells | 1 | 2017 | 29 | 0.18 | Why? |
| Adrenomedullin | 1 | 2020 | 217 | 0.17 | Why? |
| Debridement | 1 | 2017 | 172 | 0.16 | Why? |
| Cellulitis | 1 | 2017 | 119 | 0.16 | Why? |
| Toll-Like Receptors | 1 | 2019 | 365 | 0.16 | Why? |
| Adipokines | 1 | 2017 | 87 | 0.16 | Why? |
| Gram-Positive Bacteria | 1 | 2017 | 230 | 0.15 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2019 | 323 | 0.15 | Why? |
| Pulmonary Aspergillosis | 1 | 2021 | 408 | 0.15 | Why? |
| Neurodegenerative Diseases | 1 | 2021 | 469 | 0.15 | Why? |
| Abscess | 1 | 2017 | 234 | 0.14 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2019 | 398 | 0.14 | Why? |
| Emergency Service, Hospital | 2 | 2020 | 14232 | 0.13 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 7868 | 0.13 | Why? |
| Infectious Disease Incubation Period | 1 | 2020 | 1033 | 0.12 | Why? |
| Mycoses | 1 | 2019 | 589 | 0.12 | Why? |
| RNA | 1 | 2020 | 1278 | 0.12 | Why? |
| Anti-Bacterial Agents | 3 | 2019 | 10083 | 0.12 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 800 | 0.12 | Why? |
| Seroconversion | 1 | 2022 | 2515 | 0.11 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.11 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.11 | Why? |
| Mice, Inbred C57BL | 2 | 2019 | 5542 | 0.10 | Why? |
| Rats | 1 | 2017 | 2764 | 0.10 | Why? |
| Kidney Diseases | 1 | 2020 | 1434 | 0.10 | Why? |
| Combined Modality Therapy | 1 | 2017 | 3395 | 0.09 | Why? |
| Diagnosis, Differential | 2 | 2021 | 7220 | 0.08 | Why? |
| Lung Diseases | 1 | 2020 | 2361 | 0.08 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.08 | Why? |
| Antigens, Viral | 2 | 2022 | 6298 | 0.08 | Why? |
| Gene Expression Regulation | 1 | 2019 | 4020 | 0.08 | Why? |
| Germany | 2 | 2021 | 9196 | 0.08 | Why? |
| Liver | 1 | 2021 | 4007 | 0.08 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.07 | Why? |
| Organ Transplantation | 1 | 2021 | 2616 | 0.07 | Why? |
| Incidence | 3 | 2021 | 25622 | 0.07 | Why? |
| Registries | 2 | 2021 | 12327 | 0.07 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.06 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.06 | Why? |
| Immunocompromised Host | 1 | 2019 | 5150 | 0.06 | Why? |
| Humans | 19 | 2022 | 930598 | 0.06 | Why? |
| Postoperative Complications | 1 | 2021 | 5861 | 0.06 | Why? |
| Matched-Pair Analysis | 1 | 2021 | 83 | 0.06 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.06 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.05 | Why? |
| Mice | 2 | 2019 | 21357 | 0.05 | Why? |
| Viral Load | 1 | 2022 | 15850 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2021 | 5762 | 0.05 | Why? |
| Basophils | 1 | 2021 | 179 | 0.05 | Why? |
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2021 | 86 | 0.05 | Why? |
| Antibodies, Viral | 3 | 2022 | 51949 | 0.05 | Why? |
| Bile Acids and Salts | 1 | 2019 | 91 | 0.05 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.05 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
| Fatty Acids | 1 | 2019 | 238 | 0.04 | Why? |
| Stroke | 1 | 2021 | 8839 | 0.04 | Why? |
| Female | 12 | 2022 | 380317 | 0.04 | Why? |
| Estradiol | 1 | 2019 | 250 | 0.04 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 347 | 0.04 | Why? |
| Male | 11 | 2022 | 367725 | 0.04 | Why? |
| Aged | 7 | 2021 | 215776 | 0.04 | Why? |
| Immune Sera | 1 | 2020 | 884 | 0.04 | Why? |
| Critical Illness | 1 | 2019 | 17281 | 0.04 | Why? |
| Logistic Models | 2 | 2021 | 9089 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.04 | Why? |
| Glucose | 1 | 2019 | 573 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Lipopolysaccharides | 1 | 2019 | 848 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.04 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.03 | Why? |
| Endocarditis, Bacterial | 1 | 2019 | 344 | 0.03 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.03 | Why? |
| Testosterone | 1 | 2019 | 596 | 0.03 | Why? |
| Europe | 2 | 2020 | 12702 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Severity of Illness Index | 4 | 2022 | 48226 | 0.03 | Why? |
| Dendritic Cells | 1 | 2021 | 1330 | 0.03 | Why? |
| NF-kappa B | 1 | 2019 | 1301 | 0.03 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.03 | Why? |
| Animals | 2 | 2019 | 78931 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2020 | 4260 | 0.03 | Why? |
| Adult | 7 | 2022 | 244371 | 0.03 | Why? |
| Headache | 1 | 2021 | 2257 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Insulin | 1 | 2019 | 1316 | 0.03 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.03 | Why? |
| Antifungal Agents | 1 | 2021 | 1828 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.02 | Why? |
| Retrospective Studies | 2 | 2020 | 105322 | 0.02 | Why? |
| Cells, Cultured | 1 | 2021 | 5835 | 0.02 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2019 | 2483 | 0.02 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 1510 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Monocytes | 1 | 2021 | 2978 | 0.02 | Why? |
| Body Mass Index | 1 | 2020 | 4306 | 0.02 | Why? |
| Protein Domains | 1 | 2020 | 6563 | 0.02 | Why? |
| International Cooperation | 1 | 2021 | 3436 | 0.02 | Why? |
| Kidney | 1 | 2021 | 3648 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.02 | Why? |
| RNA, Messenger | 1 | 2020 | 5131 | 0.02 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.02 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Immunologic Factors | 1 | 2021 | 4206 | 0.02 | Why? |
| Neutrophils | 1 | 2021 | 5476 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.01 | Why? |
| Interleukin-6 | 1 | 2019 | 7522 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.01 | Why? |
| Public Health | 1 | 2022 | 16359 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| RNA, Viral | 1 | 2022 | 32276 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |